Antibody dynamics in children with first or repeat Plasmodium falciparum infections首次或重复感染恶性疟原虫的儿童的抗体动力学FRONTIERS IN MEDICINEIF32022-07-192OAAI
Plasmodium falciparum kelch 13 Mutations, 9 Countries in Africa 2014-2018EMERGING INFECTIOUS DISEASESIF6.62021-07-0112OAAI
Framework for Characterizing Longitudinal Antibody Response in Children After Plasmodium falciparum InfectionFRONTIERS IN IMMUNOLOGYIF5.92021-03-029OAAI
Posttreatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum MalariaJOURNAL OF INFECTIOUS DISEASESIF4.52017-12-0648OAAI
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa NetworkEMERGING INFECTIOUS DISEASESIF6.62017-12-0122OAAI
Within-host competition and drug resistance in the human malaria parasite Plasmodium falciparum人类疟原虫恶性疟原虫的宿主内竞争和耐药性PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCESIF3.52016-03-1655OAAI
Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Malaria in Children in Zaire and Uige Provinces, AngolaANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-01-0183OAAI